Structure and function of the dopamine transporter

被引:136
作者
Chen, NH
Reith, MEA
机构
[1] Univ Illinois, Coll Med, Dept Biomed & Therapeut Sci, Peoria, IL 61656 USA
[2] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China
关键词
dopamine transporter; cocaine; cocaine analog; phosphorylation; chimera; site-directed mutagenesis;
D O I
10.1016/S0014-2999(00)00563-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dopamine transporter mediates uptake of dopamine into neurons and is a major target for various pharmacologically active drugs and environmental toxins. Since its cloning, much information has been obtained regarding its structure and function. Binding domains for dopamine and various blocking drugs including cocaine an likely formed by interactions with multiple amino acid residues, some of which are separate in the primary structure but lie close together in the still unknown tertiary structure. Chimera and site-directed mutagenesis studies suggest the involvement of both overlapping and separate domains in the interaction with substrates and blockers, whereas recent findings with involvement of both overlapping and separate domains in the interaction with substrates nad blockers, binding of blockers such as cocaine. The dopamine transporter can also operate in reverse, i.e. in an efflux mode, and recent mutagenesis experiments show different structural requirements for inward and outward transport. Strong evidence for dopamine transporter domains selectively influencing binding of dopamine or cocaine analogs has not yet emerged, although the development of a cocaine antagonist at the level of the transporter remains a possibility. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:329 / 339
页数:11
相关论文
共 97 条
[1]   Neurotransmitter transporters as molecular targets for addictive drugs [J].
Amara, SG ;
Sonders, MS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :87-96
[2]  
Barker EL, 1999, J NEUROSCI, V19, P4705
[3]   Which form of dopamine is the substrate for the human dopamine transporter: The cationic or the uncharged species? [J].
Berfield, JL ;
Wang, LJC ;
Reith, MEA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4876-4882
[4]  
Bönisch H, 1998, METHOD ENZYMOL, V296, P259
[5]  
Bonisch H, 1998, Adv Pharmacol, V42, P183
[6]   Molecular cloning and functional expression of the mouse dopamine transporter -: Rapid communication [J].
Brüss, M ;
Wieland, A ;
Bönisch, H .
JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (7-8) :657-662
[7]  
Buck KJ, 1995, MOL PHARMACOL, V48, P1030
[8]   CHIMERIC DOPAMINE NOREPINEPHRINE TRANSPORTERS DELINEATE STRUCTURAL DOMAINS INFLUENCING SELECTIVITY FOR CATECHOLAMINES AND 1-METHYL-4-PHENYLPYRIDINIUM [J].
BUCK, KJ ;
AMARA, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12584-12588
[9]   Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport [J].
Burgess, KSD ;
Justice, JB .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) :656-664
[10]   AROMATIC-AROMATIC INTERACTION - A MECHANISM OF PROTEIN-STRUCTURE STABILIZATION [J].
BURLEY, SK ;
PETSKO, GA .
SCIENCE, 1985, 229 (4708) :23-28